GISAID
GISAID During the COVID-19 Pandemic
During the COVID-19 pandemic, GISAID has been the largest repository for sequenced SARS-CoV-2 genomes.
New Funding During the Pandemic
GISAID received several million dollars in additional funding for its operations during the pandemic from such sources as the World Health Organization, China, Pfizer, Janssen, and Merck.1)